Teleflex Inc (TFX)
239.18
-0.36
(-0.15%)
USD |
NYSE |
Oct 04, 16:00
239.20
+0.02
(+0.01%)
After-Hours: 20:00
Teleflex Shareholders Equity (Annual): 4.441B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 4.441B |
December 31, 2022 | 4.022B |
December 31, 2021 | 3.755B |
December 31, 2020 | 3.336B |
December 31, 2019 | 2.979B |
December 31, 2018 | 2.540B |
December 31, 2017 | 2.431B |
December 31, 2016 | 2.139B |
December 31, 2015 | 2.009B |
December 31, 2014 | 1.911B |
December 31, 2013 | 1.914B |
December 31, 2012 | 1.779B |
December 31, 2011 | 1.981B |
December 31, 2010 | 1.783B |
December 31, 2009 | 1.580B |
December 31, 2008 | 1.246B |
December 31, 2007 | 1.329B |
December 31, 2006 | 1.189B |
December 31, 2005 | 1.142B |
December 31, 2004 | 1.110B |
Date | Value |
---|---|
December 31, 2003 | 1.062B |
December 31, 2002 | 912.28M |
December 31, 2001 | 778.14M |
December 31, 2000 | 690.42M |
December 31, 1999 | 602.60M |
December 31, 1998 | 534.50M |
December 31, 1997 | 463.80M |
December 31, 1996 | 409.20M |
December 31, 1995 | 355.40M |
December 31, 1994 | 309.00M |
December 31, 1993 | 269.80M |
December 31, 1992 | 240.50M |
December 31, 1991 | 211.70M |
December 31, 1990 | 187.90M |
December 31, 1989 | 160.00M |
December 31, 1988 | 136.30M |
December 31, 1987 | 115.50M |
December 31, 1986 | 100.60M |
December 31, 1985 | 84.30M |
December 31, 1984 | 72.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
2.979B
Minimum
2019
4.441B
Maximum
2023
3.707B
Average
3.755B
Median
2021
Shareholders Equity (Annual) Benchmarks
Haemonetics Corp | 959.96M |
Abbott Laboratories | 38.60B |
Boston Scientific Corp | 19.28B |
Insulet Corp | 732.70M |
908 Devices Inc | 165.49M |